148 related articles for article (PubMed ID: 19066290)
41. Modulation of iodide uptake by dialkyl phthalate plasticisers in FRTL-5 rat thyroid follicular cells.
Wenzel A; Franz C; Breous E; Loos U
Mol Cell Endocrinol; 2005 Dec; 244(1-2):63-71. PubMed ID: 16289305
[TBL] [Abstract][Full Text] [Related]
42. Expanded high-throughput screening and chemotype-enrichment analysis of the phase II: e1k ToxCast library for human sodium-iodide symporter (NIS) inhibition.
Wang J; Richard AM; Murr AS; Buckalew AR; Lougee RR; Shobair M; Hallinger DR; Laws SC; Stoker TE
Arch Toxicol; 2021 May; 95(5):1723-1737. PubMed ID: 33656581
[TBL] [Abstract][Full Text] [Related]
43. Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I- symporter.
De la Vieja A; Ginter CS; Carrasco N
Mol Endocrinol; 2005 Nov; 19(11):2847-58. PubMed ID: 15976004
[TBL] [Abstract][Full Text] [Related]
44. [Sodium iodide symporter in physiology and diseases -- the current state of knowledge].
Wolny M; Syrenicz A
Endokrynol Pol; 2007; 58(6):512-21. PubMed ID: 18205108
[TBL] [Abstract][Full Text] [Related]
45. The Effect on Sodium/Iodide Symporter and Pendrin in Thyroid Colloid Retention Developed by Excess Iodide Intake.
Chen XY; Lin CH; Yang LH; Li WG; Zhang JW; Zheng WW; Wang X; Qian J; Huang JL; Lei YX
Biol Trace Elem Res; 2016 Jul; 172(1):193-200. PubMed ID: 26660892
[TBL] [Abstract][Full Text] [Related]
46. Development of a non-radioactive screening assay to detect chemicals disrupting the human sodium iodide symporter activity.
Dong H; Atlas E; Wade MG
Toxicol In Vitro; 2019 Jun; 57():39-47. PubMed ID: 30738889
[TBL] [Abstract][Full Text] [Related]
47. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter.
Tonacchera M; Pinchera A; Dimida A; Ferrarini E; Agretti P; Vitti P; Santini F; Crump K; Gibbs J
Thyroid; 2004 Dec; 14(12):1012-9. PubMed ID: 15650353
[TBL] [Abstract][Full Text] [Related]
48. Thyroid-stimulating hormone increases active transport of perchlorate into thyroid cells.
Tran N; Valentín-Blasini L; Blount BC; McCuistion CG; Fenton MS; Gin E; Salem A; Hershman JM
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E802-6. PubMed ID: 18303123
[TBL] [Abstract][Full Text] [Related]
49. Sodium-iodide symporter mediates iodide secretion in rat gastric mucosa in vitro.
Josefsson M; Evilevitch L; Weström B; Grunditz T; Ekblad E
Exp Biol Med (Maywood); 2006 Mar; 231(3):277-81. PubMed ID: 16514173
[TBL] [Abstract][Full Text] [Related]
50. Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line.
Arroyo-Helguera O; Anguiano B; Delgado G; Aceves C
Endocr Relat Cancer; 2006 Dec; 13(4):1147-58. PubMed ID: 17158760
[TBL] [Abstract][Full Text] [Related]
51. Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism.
Pohlenz J; Refetoff S
Biochimie; 1999 May; 81(5):469-76. PubMed ID: 10403177
[TBL] [Abstract][Full Text] [Related]
52. Conserved charged amino acid residues in the extracellular region of sodium/iodide symporter are critical for iodide transport activity.
Li CC; Ho TY; Kao CH; Wu SL; Liang JA; Hsiang CY
J Biomed Sci; 2010 Nov; 17(1):89. PubMed ID: 21092238
[TBL] [Abstract][Full Text] [Related]
53. High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter.
Stoker TE; Wang J; Murr AS; Bailey JR; Buckalew AR
Chem Res Toxicol; 2023 Mar; 36(3):380-389. PubMed ID: 36821091
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and evaluation of photoreactive probes to elucidate iodide efflux in thyrocytes.
Derbré S; Lecat-Guillet N; Pillon F; Ambroise Y
Bioorg Med Chem Lett; 2009 Feb; 19(3):825-7. PubMed ID: 19103483
[TBL] [Abstract][Full Text] [Related]
55. High-throughput screening and chemotype-enrichment analysis of ToxCast phase II chemicals evaluated for human sodium-iodide symporter (NIS) inhibition.
Wang J; Hallinger DR; Murr AS; Buckalew AR; Lougee RR; Richard AM; Laws SC; Stoker TE
Environ Int; 2019 May; 126():377-386. PubMed ID: 30826616
[TBL] [Abstract][Full Text] [Related]
56. Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies.
Heufelder AE; Morgenthaler N; Schipper ML; Joba W
Thyroid; 2001 Sep; 11(9):839-47. PubMed ID: 11575853
[TBL] [Abstract][Full Text] [Related]
57. Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter.
Nicola JP; Carrasco N; Amzel LM
Nat Commun; 2014 Jun; 5():3948. PubMed ID: 24888603
[TBL] [Abstract][Full Text] [Related]
58. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
Paroder V; Nicola JP; Ginter CS; Carrasco N
J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
[TBL] [Abstract][Full Text] [Related]
59. From the molecular characterization of iodide transporters to the prevention of radioactive iodide exposure.
Dayem M; Navarro V; Marsault R; Darcourt J; Lindenthal S; Pourcher T
Biochimie; 2006 Nov; 88(11):1793-806. PubMed ID: 16905238
[TBL] [Abstract][Full Text] [Related]
60. Structural insights into the mechanism of the sodium/iodide symporter.
Ravera S; Nicola JP; Salazar-De Simone G; Sigworth FJ; Karakas E; Amzel LM; Bianchet MA; Carrasco N
Nature; 2022 Dec; 612(7941):795-801. PubMed ID: 36517601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
